🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseHas anyone dealt with glp-1 hepatoprotection? Page 6

Has anyone dealt with glp-1 hepatoprotection?

GenomicsKate Fri, Jul 11, 2025 at 12:32 PM 33 replies 1,678 viewsPage 6 of 7
carl_compliance
Member
234
1,123
Nov 2024
Raleigh, NC
Jul 26, 2025 at 4:08 AM#26

One thing that is still open after PeptideChemSF’s answer:

What did you change at the same time, and can you separate the two now?

Last edited: Jul 26, 2025 at 7:08 AM
39 12labquiet_amy, emily_PDX, Dr.SleepRoch and 36 others
Reply Quote Save Share Report
laura_annarbor
Member
189
890
Dec 2024
Ann Arbor, MI
Jul 27, 2025 at 9:11 PM#27
DoseLogDan said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

This is where I part company with the consensus forming above. The objection nobody has made: this only works if the measurement is doing what we assume it is doing, and that assumption has not been tested here.

Last edited: Jul 27, 2025 at 11:11 PM
40 13emily_PDX, Dr.SleepRoch, laura_annarbor and 37 others
Reply Quote Save Share Report
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Jul 29, 2025 at 2:13 PM#28
DoseLogDan said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

41 14josh_phd_bmore, roxy_nash, tony_orlando and 38 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
FDA_TrackerJim
Senior Member
1,567
7,890
Feb 2024
Rockville, MD
Jul 31, 2025 at 7:14 AM#29
DoseLogDan said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Genuinely useful, thank you. I had the facts and not the framework. Taking it to my next appointment.

Last edited: Jul 31, 2025 at 10:14 AM
42 15Dr.LeslieOBGYN, MikeNYC_runner and 39 others
Reply Quote Save Share Report
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
Aug 2, 2025 at 12:14 AM#30

Reporting back.

Update: the thing I was blaming turned out not to be the cause. Leaving the original post as written rather than editing it, so the mistake stays visible for whoever searches this next.

14 12claudia_zurich, nancy_portland, rick_sfbay and 11 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register